Unknown

Dataset Information

0

Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.


ABSTRACT: Background:Cannabis is a widely used drug in the United States, and the frequency of cannabis use in the human immunodeficiency virus (HIV)-infected population is disproportionately high. Previous human and macaque studies suggest that cannabis may have an impact on plasma viral load; however, the relationship between cannabis use and HIV-associated systemic inflammation and immune activation has not been well defined. Methods:The impact of cannabis use on peripheral immune cell frequency, activation, and function was assessed in 198 HIV-infected, antiretroviral-treated individuals by flow cytometry. Individuals were categorized into heavy, medium, or occasional cannabis users or noncannabis users based on the amount of the cannabis metabolite 11-nor-carboxy-tetrahydrocannabinol (THC-COOH) detected in plasma by mass spectrometry. Results:Heavy cannabis users had decreased frequencies of human leukocyte antigen (HLA)-DR+CD38+CD4+ and CD8+ T-cell frequencies, compared to frequencies of these cells in non-cannabis-using individuals. Heavy cannabis users had decreased frequencies of intermediate and nonclassical monocyte subsets, as well as decreased frequencies of interleukin 23- and tumor necrosis factor-?-producing antigen-presenting cells. Conclusions:While the clinical implications are unclear, our findings suggest that cannabis use is associated with a potentially beneficial reduction in systemic inflammation and immune activation in the context of antiretroviral-treated HIV infection.

SUBMITTER: Manuzak JA 

PROVIDER: S-EPMC6248381 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.

Manuzak Jennifer A JA   Gott Toni M TM   Kirkwood Jay S JS   Coronado Ernesto E   Hensley-McBain Tiffany T   Miller Charlene C   Cheu Ryan K RK   Collier Ann C AC   Funderburg Nicholas T NT   Martin Jeffery N JN   Wu Michael C MC   Isoherranen Nina N   Hunt Peter W PW   Klatt Nichole R NR  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20180601 12


<h4>Background</h4>Cannabis is a widely used drug in the United States, and the frequency of cannabis use in the human immunodeficiency virus (HIV)-infected population is disproportionately high. Previous human and macaque studies suggest that cannabis may have an impact on plasma viral load; however, the relationship between cannabis use and HIV-associated systemic inflammation and immune activation has not been well defined.<h4>Methods</h4>The impact of cannabis use on peripheral immune cell f  ...[more]

Similar Datasets

| S-EPMC5848260 | biostudies-literature
| S-EPMC4957444 | biostudies-literature
| S-EPMC5338340 | biostudies-literature
| S-EPMC6467189 | biostudies-literature
| S-EPMC4573418 | biostudies-literature
| S-EPMC5604865 | biostudies-literature
| S-EPMC8139695 | biostudies-literature
| S-EPMC4943535 | biostudies-literature
| S-EPMC8631166 | biostudies-literature
| S-EPMC5407055 | biostudies-literature